Study: 4th vaccine dose not very effective against Omicron

 https://www.israelnationalnews.com/news/320643

Preliminary results from the first study of its kind in the world, led by Sheba Medical Center, on the safety and efficacy of the fourth dose of the coronavirus vaccine, indicate a significant increase in antibody levels, but this level of protection is only partially effective against the Omicron variant.

The study, led by Prof. Gili Regev-Yohai, director of the Infection Prevention and Control Unit at Sheba Medical Center, examined the rate of increase in antibodies after the fourth vaccine of both the Pfizer and Moderna vaccines was administered, compared to a control group.

Preliminary results from the first study of its kind in the world, led by Sheba Medical Center, on the safety and efficacy of the fourth dose of the coronavirus vaccine, indicate a significant increase in antibody levels, but this level of protection is only partially effective against the Omicron variant.

The study, led by Prof. Gili Regev-Yohai, director of the Infection Prevention and Control Unit at Sheba Medical Center, examined the rate of increase in antibodies after the fourth vaccine of both the Pfizer and Moderna vaccines was administered, compared to a control group.